Clinical Trials Directory

Trials / Unknown

UnknownNCT02726633

Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer

Evaluate the Utility of the ProLung China Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Chinese Alliance Against Lung Cancer · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A Study to evaluate the utility of the ProLung China Test as an adjunct to CT scan in the diagnosis of lung cancer.

Detailed description

This Study will assess the stability of the ProLung China Test classification algorithm when used as an adjunct to CT scan. This Study will assess whether there are any potential safety concerns of the ProLung China Test when used to evaluate patients with a positive CT scan for lung cancer.

Conditions

Timeline

Start date
2015-05-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-04-04
Last updated
2017-04-04

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02726633. Inclusion in this directory is not an endorsement.